Detalles de la búsqueda
1.
One year of sitagliptin treatment protects against islet amyloid-associated ß-cell loss and does not induce pancreatitis or pancreatic neoplasia in mice.
Am J Physiol Endocrinol Metab
; 305(4): E475-84, 2013 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23736544
2.
Increased lymphocyte infiltration in patients with head and neck cancer treated with the IRX-2 immunotherapy regimen.
Cancer Immunol Immunother
; 61(6): 771-82, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22057678
3.
HER2 in well differentiated breast cancer: is testing necessary?
Breast Cancer Res Treat
; 112(3): 551-6, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18202913
4.
High concordance between immunohistochemistry and fluorescence in situ hybridization testing for HER2 status in breast cancer requires a normalized IHC scoring system.
Mod Pathol
; 21(10): 1271-7, 2008 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-18487992
5.
HER-2 testing in breast cancer using parallel tissue-based methods.
JAMA
; 291(16): 1972-7, 2004 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-15113815
6.
Predicting degree of benefit from adjuvant trastuzumab in NSABP trial B-31.
J Natl Cancer Inst
; 105(23): 1782-8, 2013 Dec 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-24262440
7.
Determining true HER2 gene status in breast cancers with polysomy by using alternative chromosome 17 reference genes: implications for anti-HER2 targeted therapy.
J Clin Oncol
; 29(31): 4168-74, 2011 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21947821
8.
Positive response to neoadjuvant cyclophosphamide and doxorubicin in topoisomerase II nonamplified/HER2/neu negative/polysomy 17 absent breast cancer patients.
Cancer Manag Res
; 2: 213-8, 2010 Aug 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-21188112
9.
Human epidermal growth factor receptor 2 assessment in a case-control study: comparison of fluorescence in situ hybridization and quantitative reverse transcription polymerase chain reaction performed by central laboratories.
J Clin Oncol
; 28(28): 4300-6, 2010 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20697093
10.
Relationship between clinical and pathologic features of ductal carcinoma in situ and patient age: an analysis of 657 patients.
Am J Surg Pathol
; 33(12): 1802-8, 2009 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19950406
11.
Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 cases.
Breast Cancer Res Treat
; 110(3): 417-26, 2008 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-17912629
12.
Concordance between human epidermal growth factor receptor 2 testing by reverse transcriptase polymerase chain reaction and fluorescent in situ hybridization.
J Clin Oncol
; 30(14): 1726-7; author reply 1728-9, 2012 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-22493420
13.
The knowns and the unknowns in HER2 testing in breast cancer.
Am J Clin Pathol
; 136(1): 5-6, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21685025
14.
Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survival.
J Clin Oncol
; 24(36): 5637-44, 2006 Dec 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-17116944
Resultados
1 -
14
de 14
1
Próxima >
>>